NCT02922166View on ClinicalTrials.gov

Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans

PHASE1UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 3, 2017

Primary Completion Date

May 10, 2019

Study Completion Date

December 31, 2019

Conditions
FearAnxiety
Interventions
DRUG

SRX246

oral capsule

DRUG

Placebo

oral capsule

Trial Locations (1)

20892

National Institute of Mental Health, Bethesda

Sponsors
All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Azevan Pharmaceuticals

INDUSTRY

NCT02922166 - Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans | Biotech Hunter | Biotech Hunter